From 2,000+ patients · Oral Wegovy vs Wegovy is already seeing results
Oral Wegovy vs Wegovy: both are FDA-approved GLP-1 medications for weight loss. Oral Wegovy (semaglutide) and Wegovy (semaglutide) differ in mechanism and clinical efficacy. Weight Method offers both from $199/month with virtual consultations and licensed providers.
Overview
Wegovy (injectable semaglutide 2.4 mg weekly) was FDA-approved in 2021 for chronic weight management. In 2025, Novo Nordisk launched Oral Wegovy — a high-dose daily semaglutide tablet (25–50 mg) also FDA-approved for chronic weight management. These are two separate FDA-approved products that share the same active ingredient and indication but differ in delivery route. Weight Method does not dispense or prescribe either brand-name product; our program provides compounded semaglutide through licensed providers and U.S.-licensed pharmacies. Which option is appropriate for you is a decision made by a licensed provider based on your individual medical profile.
Key Fact
Oral Wegovy (semaglutide 25–50 mg daily) and injectable Wegovy (semaglutide 2.4 mg weekly) are two FDA-approved products for chronic weight management from Novo Nordisk that differ in delivery route. The oral dose is higher than the injectable dose because only a small fraction of oral semaglutide is absorbed. Both are different from Weight Method's compounded program.
Source: FDA prescribing information (Wegovy; Oral Wegovy)
Oral Wegovy
Wegovy
| Oral Wegovy | Wegovy | |
|---|---|---|
| Manufacturer | Novo Nordisk | Novo Nordisk |
| Active Ingredient | semaglutide | semaglutide |
| FDA Indication | Chronic weight management | Chronic weight management |
| FDA Approval | 2025 | 2021 |
| Formulation | Oral tablet | Injectable pen |
| Frequency | Once daily | Once weekly |
| Available Doses | 25mg, 50mg | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
| Avg. Weight Loss | 15-17% | 15-17% |
| Our Price | $199/mo | $199/mo |
Key Differences
Oral Wegovy and injectable Wegovy share the same active ingredient and FDA-approved indication; the difference is the delivery route (daily oral tablet vs. weekly injection) and the associated dosing and administration requirements. The oral dose (25–50 mg) is higher than the injectable dose (2.4 mg) because oral bioavailability is low. Which option is clinically appropriate for any individual depends on that person's medical history and preferences and is determined by a licensed provider. Both are different from Weight Method's compounded semaglutide, available at $154/mo.
Verdict
Oral Wegovy and injectable Wegovy are two FDA-approved Novo Nordisk products that differ in delivery route; neither is what Weight Method dispenses. The right option for an individual depends on that person's medical profile and preferences and is determined by a licensed provider. Weight Method's compounded semaglutide is available at $154/mo.
Ready to Get Started?
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityYour Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
Semaglutide
Compounded semaglutide. Once-weekly subcutaneous injection.
- Weekly injection
- Gradual dose increase
- Provider monitoring
- Free shipping
Tirzepatide
Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
- Weekly injection
- Dual hormone action
- Provider monitoring
- Free shipping
Frequently Asked Questions
Ready to Get Started?
Take our 2-minute quiz to see if you qualify for GLP-1 treatment.
Start QuizFree consultation. No commitment.